Deutivacaftor

Brand name: Alyfrek

B

Score B — Known Hepatotoxin

This drug is known or highly likely to cause idiosyncratic liver injury and has a characteristic signature.

Between 12 and 50 cases including small case series have been described in the medical literature.

Primary class Genetic
Secondary class Cystic fibrosis
FDA approval 2025